Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-24

Clinical Trial Update: Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis [Phase 2, Phase 3]

View source ↗

Summary

This update indicates the pilot phase 2/3 trial of acitretin for severe chronic hand dermatitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acitretin (Acitretin)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Chronic Hand Dermatitis | Phase 2, Phase 3 | Status: COMPLETED